See also:Flaws in design, execution and interpretation limit CLARITY‐BPA’s value for risk assessments of bisphenol A The draft of a new study by the FDA on the safety of Bisphenol A (BPA) is a glaring example of substandard federal regulatory science that continues to place public health at risk. The study is rife with amateurish […]